462 related articles for article (PubMed ID: 27373493)
1. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
[TBL] [Abstract][Full Text] [Related]
2. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
Liddicoat BJ; Chalk AM; Walkley CR
Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
[TBL] [Abstract][Full Text] [Related]
3. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
[TBL] [Abstract][Full Text] [Related]
4. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
[TBL] [Abstract][Full Text] [Related]
5. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
6. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
7. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
10. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
[TBL] [Abstract][Full Text] [Related]
11. Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis.
Vlachogiannis NI; Tual-Chalot S; Zormpas E; Bonini F; Ntouros PA; Pappa M; Bournia VK; Tektonidou MG; Souliotis VL; Mavragani CP; Stamatelopoulos K; Gatsiou A; Sfikakis PP; Stellos K
J Autoimmun; 2021 Dec; 125():102755. PubMed ID: 34857436
[TBL] [Abstract][Full Text] [Related]
12. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
13. Editing of messenger RNA precursors and of tRNAs by adenosine to inosine conversion.
Keller W; Wolf J; Gerber A
FEBS Lett; 1999 Jun; 452(1-2):71-6. PubMed ID: 10376681
[TBL] [Abstract][Full Text] [Related]
14. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis.
Wang Q; Khillan J; Gadue P; Nishikura K
Science; 2000 Dec; 290(5497):1765-8. PubMed ID: 11099415
[TBL] [Abstract][Full Text] [Related]
15. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
16. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
17. Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.
Vlachogiannis NI; Gatsiou A; Silvestris DA; Stamatelopoulos K; Tektonidou MG; Gallo A; Sfikakis PP; Stellos K
J Autoimmun; 2020 Jan; 106():102329. PubMed ID: 31493964
[TBL] [Abstract][Full Text] [Related]
18. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
Toth AM; Li Z; Cattaneo R; Samuel CE
J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
[TBL] [Abstract][Full Text] [Related]
19. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
20. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
